Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3498

Hengrui, one of China's leading biotechs, anticipates $1.2B in proposed Hong Kong listing

$
0
0
Jiangsu Hengrui, a 55-year-old drugmaker that has become one of China's leading forces in biotech, expects net proceeds of about 9.4 billion Hong Kong dollars ($1.2 billion) from its proposed float on the Hong Kong ...

Viewing all articles
Browse latest Browse all 3498

Trending Articles